Researchers trial inhaled versions of Oxford and Imperial COVID-19 vaccine candidates

By Alistair Smout LONDON (Reuters) - Inhaled versions of COVID-19 vaccine candidates developed by Oxford University and Imperial College will be trialled to see if they deliver a localised immune response in the respiratory tract, British researchers said on Monday.

Reuters September 15, 2020 00:12:23 IST
Researchers trial inhaled versions of Oxford and Imperial COVID-19 vaccine candidates

Researchers trial inhaled versions of Oxford and Imperial COVID19 vaccine candidates

By Alistair Smout

LONDON (Reuters) - Inhaled versions of COVID-19 vaccine candidates developed by Oxford University and Imperial College will be trialled to see if they deliver a localised immune response in the respiratory tract, British researchers said on Monday.

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Chris Chiu, of Imperial's Department of Infectious Disease, said there was evidence that flu vaccines delivered by nasal spray could protect against and reduce transmission of the disease.

"We are keen to explore if this may also be the case for SARS-CoV-2 and whether delivering COVID-19 vaccines to the respiratory tract is safe and produces an effective immune response," he said in a statement.

Trials of the Oxford vaccine, which has been licensed to AstraZeneca, resumed at the weekend after safety watchdogs gave it the go-ahead. Late-stage trials had been paused after study subject fell in Britain.

"We have already shown that (Oxford vaccine) ChAdOx1 nCoV-19 (AZD1222) is safe and induces strong immune responses after intramuscular injection," said Sarah Gilbert of the University of Oxford.

"Delivering the vaccine to the respiratory tract instead may be a good approach to inducing immune responses in the best place to enable a rapid response after exposure to airborne virus."

Imperial's vaccine is also in clinical trials, although at an earlier stage.

The new trials of the vaccines will see volunteers receive aerosolised vaccines through a nebulizer, delivering the vaccine as airborne droplets through a mouthpiece. A total of 30 people will be recruited to the trials.

Previous studies suggest that lower doses might be required than in intramuscular injections to give protection, the Imperial researchers said.

(Reporting by Alistair Smout; Editing by Hugh Lawson)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Government aid, stock gains push U.S. wealth to pre-pandemic levels, Fed says
Business

Government aid, stock gains push U.S. wealth to pre-pandemic levels, Fed says

By Howard Schneider WASHINGTON (Reuters) - A rebounding stock market and massive federal aid payments pushed the net worth of U.S. households back to pre-coronavirus levels in the second quarter, the Federal Reserve reported on Monday, with savings accounts and equity portfolios both rising sharply despite the pandemic

Traders shun risky assets as new lockdowns loom
Business

Traders shun risky assets as new lockdowns loom

By Rodrigo Campos NEW YORK (Reuters) - Stocks across the world hit their lowest in seven weeks and other risk assets sold off on Monday on concerns over renewed lockdown measures in Europe and Britain, as well as the United States' inability to agree on fiscal stimulus that would support millions of unemployed. Oil prices fell nearly 5%, the dollar rallied and an index of emerging market currencies fell by the most in six months. The MSCI world equity index , which tracks shares in 49 countries, touched its lowest since Aug.

Traders shun risky assets as new lockdowns loom; stocks, oil tumble
Business

Traders shun risky assets as new lockdowns loom; stocks, oil tumble

By Rodrigo Campos NEW YORK (Reuters) - Stocks across the world hit their lowest in seven weeks and other risk assets also sold off on Monday on concerns over renewed lockdown measures in Europe and Britain, as well as the United States' inability to agree on fiscal stimulus that would support millions of unemployed. Oil prices fell more than 3%, the dollar rose against a basket of peers and an index of emerging market currencies fell by the most in six months. The MSCI world equity index , which tracks shares in 49 countries, ended at its lowest since Aug